IOSP reports double-digit sales and operating income growth in Q2 2026, driven by a 15% rise in Performance Chemicals operating income.
Innospec posted a 15% increase in operating income for Q2 2026, with all business segments contributing to double-digit sales and profit growth. The company attributed the gains to strong operating leverage in its Performance Chemicals unit, which offset broader market challenges.
The results follow a period of capacity constraints, with management noting that repairs in North Carolina will boost Performance Chemicals capacity by over 10% next year. Full optimization of the expanded capacity is expected by the end of Q4, potentially supporting further margin expansion.
Shares of IOSP showed muted reaction in after-hours trading, as investors awaited details on the timeline for capacity ramp-up and its impact on future earnings.